NASDAQ:NTLA | Insider Transactions — Page 4 | Intellia Therapeutics, Inc.

NTLA Insider Transactions — Page 4

322 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–322; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
OrbiMed Capital GP V LLCDirector2016-05-11Purchase58,534.0$18.0
OrbiMed Global Healthcare GP LLCDirector2016-05-11Purchase58,534.0$18.0
ISALY SAMUEL DDirector2016-05-11Purchase191,466.0$18.0
ORBIMED ADVISORS LLCDirector2016-05-11Purchase191,466.0$18.0
OrbiMed Capital GP V LLCDirector2016-05-11Purchase191,466.0$18.0
OrbiMed Global Healthcare GP LLCDirector2016-05-11Purchase191,466.0$18.0
Temasek Holdings (Private) LtdTenPercentOwner2016-05-11Purchase300,000.0$18.0
Fullerton Management Pte LtdTenPercentOwner2016-05-11Purchase300,000.0$18.0
Temasek Life Sciences Private LtdTenPercentOwner2016-05-11Purchase300,000.0$18.0
TLS Beta Pte. Ltd.TenPercentOwner2016-05-11Purchase300,000.0$18.0
BAKER JULIANOther2016-05-11Purchase179,531.0$18.0
BAKER FELIXOther2016-05-11Purchase179,531.0$18.0
BAKER BROS. ADVISORS LPOther2016-05-11Purchase179,531.0$18.0
Baker Bros. Advisors (GP) LLCOther2016-05-11Purchase179,531.0$18.0
BAKER JULIANOther2016-05-11Purchase20,469.0$18.0
BAKER FELIXOther2016-05-11Purchase20,469.0$18.0
BAKER BROS. ADVISORS LPOther2016-05-11Purchase20,469.0$18.0
Baker Bros. Advisors (GP) LLCOther2016-05-11Purchase20,469.0$18.0
NOVARTIS AGTenPercentOwner2016-05-11Purchase277,777.0$18.0
Novartis Institutes for BioMedical Research, Inc.TenPercentOwner2016-05-11Purchase277,777.0$18.0
GORDON CARL LDirector2016-05-11Purchase58,534.0$18.0
GORDON CARL LDirector2016-05-11Purchase191,466.0$18.0